ProCE Banner Activity

CE / CME

Diabetes Medical Minute Topic 3: Incorporating CGM Into Practice

Multimedia
Expert insights on when and how to integrate continuous glucose monitoring into the care of patients with type 1 and type 2 diabetes.

Registered Nurses: 0.25 Nursing contact {hour}

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Released: March 20, 2020

Expiration: March 19, 2021

No longer available for credit.

Share

Faculty

Vivian A. Fonseca

Vivian A. Fonseca, MD, FRCP

Professor of Medicine and Pharmacology
Assistant Dean for Clinical Research
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences center
New Orleans, Louisiana

Diana Isaacs

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP

Endocrine Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator

Endocrinology and Metabolism Institute
Cleveland Clinic
Cleveland, Ohio

Pamela Kushner

Pamela Kushner, MD, FAAFP

Clinical Professor
University of California Irvine Medical Center
Irvine, California
Director
Kushner Wellness
Los Alamitos, California

Provided by

Provided by the Endocrine Society, in collaboration with Clinical Care Options.
ProCE Banner

Supporters

Supported by an educational grant from

Lilly

Partners

ADCES

ProCE Banner

Target Audience

The target audience for these activities are endocrinologists (including MD, DO, NP, and PA), primary care clinicians (including MD, DO, NP, and PA), and other healthcare providers who are part of the diabetes care team including nurses, certified diabetes educators, pharmacists, and registered dieticians.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Explain the role of CGM in reducing postprandial hyperglycemia, increasing time in range, improving A1C, and reducing diabetes stress
  • Compare and contrast available and emerging CGM devices
  • Employ a stepped approach to reviewing and interpreting CGM data in order to develop a personalized management plan with patients
  • Collaborate with the diabetes healthcare team (ie, specialist, primary care clinician, diabetes educator) to improve adoption of CGM devices in practice

Program Director Disclosure

Program Director

Vivian A. Fonseca, MD, FRCP

Professor of Medicine and Pharmacology
Assistant Dean for Clinical Research
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences center
New Orleans, Louisiana

Vivian A. Fonseca, MD, FRCP, has disclosed that he has received funds for research support (paid to his institution) from Bayer and Boehringer Ingelheim; has received consulting fees from Abbott, Asahi Kasei, AstraZeneca, Intarcia, Lilly, Novo Nordisk, Sanofi, and Takeda; and owns stock or stock options in Amgen, BRAVO4Health, Insulin Algorithms, and Microbiome Technologies.

Faculty Disclosure

Primary Author

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP

Endocrine Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator

Endocrinology and Metabolism Institute
Cleveland Clinic
Cleveland, Ohio

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDE, has disclosed that she has received consulting fees from Dexcom, Novo, and LifeScan.

Pamela Kushner, MD, FAAFP

Clinical Professor
University of California Irvine Medical Center
Irvine, California
Director
Kushner Wellness
Los Alamitos, California

Pamela Kushner, MD, FAAFP, has disclosed that she has received consulting fees from AstraZeneca, Janssen, Lilly, and Novo Nordisk and fees for non-CME/CE services from AstraZeneca, Janssen, and Novo Nordisk.

Staff Disclosure

Staff

Megan Cartwright, PhD

Senior Clinical Editor

Megan Cartwright, PhD, has no relevant conflicts of interest to report.

Sharon Hwang, MD, MPH

Editorial Contributor

Sharon Hwang, MD MPH, has no relevant conflicts of interest to disclose.

Kiran Mir-Hudgeons, PhD

Clinical Editor

Kiran Mir-Hudgeons, PhD, has no relevant conflicts of interest to report.

Zachary Schwartz, MSc, ELS

Scientific Director

Zachary Schwartz, MSc, has no relevant conflicts of interest to report.

Carolyn Skowronski, PharmD

Associate Director, Scientific Services

Carolyn Skowronski, PharmD, has no relevant conflicts of interest to report.

Instructions for Credit

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Association of Diabetes Care & Education Specialists is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This program provides 0.25 contact hour of continuing education credit.

Provider approved by the California Board of Registered Nursing, Provider #10977, for 0.25 Contact Hour. RNs must retain this document for 4 years after the activity concludes

Additional Information

Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 20, 2020, through March 19, 2021:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve learner knowledge and competence in managing glycemic control in patients with diabetes by providing timely treatment intensification according to the guidelines and applying evidence-based treatment strategies for patients with diabetes.